![Igal Kohn](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Igal Kohn currently works at Elcam Medical ACS Ltd., as Chief Executive Officer from 2017, NanoPass Technologies Ltd., as Director, and DiagnosTear Technologies, Inc., as Independent Director from 2024.
Postes actifs de Igal Kohn
| Sociétés | Poste | Début |
|---|---|---|
Elcam Medical ACS Ltd.
 Elcam Medical ACS Ltd. Medical SpecialtiesHealth Technology Manufactures and supplies injection-molded disposable medical devices | Directeur Général | 01/01/2017 |
NanoPass Technologies Ltd.
 NanoPass Technologies Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
21
Relations au 1er degré
2
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
NanoPass Technologies Ltd.
NanoPass Technologies Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals | Health Technology |
Elcam Medical ACS Ltd.
Elcam Medical ACS Ltd. Medical SpecialtiesHealth Technology Manufactures and supplies injection-molded disposable medical devices | Health Technology |
